Exosomes, vesicles and particles are no longer obscure
The launch of the Centre for Applied Nanomedicine at the RI-MUHC opens an ecosystem of possibilities to the research community
The 2023 McGill Clinical Innovation Competition results are out
RI-MUHC researchers and trainees collaborate on four winning teams
RI-MUHC trainee honoured by the Canadian Association for HIV Research
Wesal Elgretli’s M.Sc. project underlines the importance of addressing liver disease simultaneously with HCV infection
RI-MUHC technology platforms form new partnerships to accelerate research and drug discovery
Partnerships between NMX Research and Solutions, the RI-MUHC...
Dr. Andrey Cybulsky awarded Medal for Research Excellence
Understanding and developing better treatments for glomerular disease is the life’s work of this RI-MUHC researcher
Getting things started at the McGill Antimicrobial Resistance Centre
RI-MUHC and McGill researchers join forces against a major global threat to human health
MedSafer wins First Jury Prize in Acfas Génies en affaires competition
Designed by MUHC clinicians and researchers, MedSafer is an application that helps reduce drug prescriptions...
Five RI-MUHC researchers receive new funding from MI4
Innovative approaches in addressing pandemic threats, antimicrobial resistance, and the microbes that shape human health were supported in...
Equitable diagnosis for chlamydia and gonorrhea screening worldwide is the aim of one RI-MUHC trainee
Fio Vialard’s publication in BMJ Sexually Transmitted Infections will help policymakers customize...
Bertrand Lebouché wins the CAHR-CANFAR Excellence in Research Award
Deeply committed to outreach, Dr. Lebouché is being recognized for conducting patient-oriented...